1Y Close · As of Aug 26, 2026
Biotoxtech operates in the Professional Services sector.
Legal name: BiotoxtechCo.,Ltd.
In fiscal year 2025, Biotoxtech (086040) reported revenue of 47.0 billion KRW, up 13.7% from 41.3 billion KRW a year earlier.
Operating profit was -4.8 billion KRW and net income was -1.6 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 39.7 billion KRW, with a P/B of 1.24.
These figures can be verified in the DART filing (receipt no. 20260319000711).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 47.0B | -4.8B | -1.6B |
| 2024 | 41.3B | -8.9B | -12.7B |
| 2023 | 32.6B | -8.2B | -9.0B |
Recent Filings
Officer/Major Shareholder Ownership Report
Large Shareholding Report (General)
Semi-Annual Report (2026.06)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-26 | Officer/Major Shareholder Ownership Report |
| 2026-08-26 | Large Shareholding Report (General) |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-06 | Officer/Major Shareholder Ownership Report |
| 2026-08-06 | Large Shareholding Report (General) |